Zevra Therapeutics (ZVRA) Cost of Revenue (2019 - 2026)
Zevra Therapeutics (ZVRA) posted Cost of Revenue of $1.53 million for Q2 2026, down 87.7% from $12.38 million a year earlier and down 19.6% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Cost of Revenue (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Cost of Revenue at Zevra Therapeutics was $6.18 million, down 64.5% year-over-year; for FY2025, it was $16.48 million, up 122.2% from FY2024.
- Annual Cost of Revenue has increased for three consecutive years, with a four-year compound annual growth rate of 68.2% (FY2021 to FY2025).
- In prior years, Zevra Therapeutics' Cost of Revenue was $7.42 million in FY2024 (+241.3%), $2.17 million in FY2023 (+878.8%), $222,000 in FY2022 (-89.2%) and $2.06 million in FY2021.
- Quarterly Cost of Revenue has run from a low of $8,000 in Q1 2022 to a high of $12.38 million in Q2 2025 over five years.
- On a year-over-year basis, Cost of Revenue increased in five of the last seven quarters, with growth averaging 120.7%.
- The strongest year-over-year quarter for Cost of Revenue in the past five years was Q1 2025, with growth of 668.6%; the weakest was Q2 2022, with a decline of 94.9%.
- According to Business Quant data, Cost of Revenue for the three prior quarters was $1.9 million (Q1 2026), $1.52 million (Q4 2025) and $1.24 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Zevra Therapeutics | 592.83 Mn | -219.88 Mn | 38.18 Mn | 1.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.53 Mn |
| Mar 31, 2026 | 1.90 Mn |
| Dec 31, 2025 | 1.52 Mn |
| Sep 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | 12.38 Mn |
| Mar 31, 2025 | 1.35 Mn |
| Dec 31, 2024 | 1.37 Mn |
| Sep 30, 2024 | 2.30 Mn |
| Jun 30, 2024 | 3.57 Mn |
| Mar 31, 2024 | 175,000.00 |
| Dec 31, 2023 | 1.23 Mn |
| Sep 30, 2023 | 144,000.00 |
| Jun 30, 2023 | 677,000.00 |
| Mar 31, 2023 | 125,000.00 |
| Dec 31, 2022 | 22,000.00 |
| Sep 30, 2022 | 141,000.00 |
| Jun 30, 2022 | 51,000.00 |
| Mar 31, 2022 | 8,000.00 |
| Dec 31, 2021 | 59,000.00 |
| Jun 30, 2021 | 1.00 Mn |
API Access
Zevra Therapeutics Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();